BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2144751)

  • 1. Proton nuclear magnetic resonance spectroscopy of serum lipoproteins in rabbits with implanted VX-2 carcinoma.
    Gadeholt G; Kruse S; Halsteinslid L; Sletten E
    Eur J Cancer; 1990; 26(5):611-5. PubMed ID: 2144751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton nuclear magnetic resonance spectroscopy of plasma lipoproteins in head and neck cancer patients.
    Chow JM; Gotsis ED; Jarc M; Dillon JT; Wyrwicz AM; Applebaum EL
    Am J Otolaryngol; 1990; 11(5):332-8. PubMed ID: 2264585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of malignant tumours by multivariate analysis of proton magnetic resonance spectra of serum.
    Sletten E; Kvalheim OM; Kruse S; Farstad M; Søreide O
    Eur J Cancer; 1990; 26(5):615-8. PubMed ID: 2144752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of proton nuclear magnetic resonance spectroscopy for detection of malignancy.
    Wilding P; Senior MB; Inubushi T; Ludwick ML
    Clin Chem; 1988 Mar; 34(3):505-11. PubMed ID: 3349601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton nuclear magnetic resonance spectroscopy of plasma lipoproteins in malignancy.
    Nabholtz JM; Rossignol A; Farnier M; Gambert P; Tremeaux JC; Friedman S; Guerrin J
    Acta Oncol; 1988; 27(5):479-82. PubMed ID: 3203006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [H-NMR spectroscopy of plasma cannot be used for cancer screening].
    Tran Dinh S; Schlumberger M; Gicquel C; Neumann JM; Hervé M; Turpin G; Parmentier C
    Bull Cancer; 1988; 75(8):795-800. PubMed ID: 3179513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of triglyceride levels on methyl and methylene envelope line widths in proton nuclear magnetic resonance spectroscopy of human plasma.
    Mims MP; Morrisett JD; Mattioli CA; Gotto AM
    N Engl J Med; 1989 Jun; 320(22):1452-7. PubMed ID: 2716796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin treatment of rabbit renal VX-2 carcinoma: nephrotoxicity, serum parameters and weight.
    Gadeholt-Göthlin G; Vik H; Göthlin JH
    Urol Res; 1995; 23(3):169-73. PubMed ID: 7483143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton nuclear magnetic resonance methyl and methylene linewidths from plasma decrease during postprandial lipemia.
    Verdery RB; Benham DF; McLennan I; Busby MJ; Wehrle JP; Glickson JD
    Biochim Biophys Acta; 1989 Dec; 1006(3):287-90. PubMed ID: 2597673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton NMR spectroscopy of plasma lipoproteins: a marker of the immune function in cancer disease?
    Leray G; de Certaines JD
    Anticancer Res; 1994; 14(5A):1839-51. PubMed ID: 7847817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of malignant tumors: water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.
    Dowd TL; Kaplan BA; Gupta RK; Aisen P
    Magn Reson Med; 1987 Oct; 5(4):395-7. PubMed ID: 3683172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor detection in serum by NMR spectrometry. A critical evaluation of the so-called Fossel test].
    Schalk KP; Rüterjans H; Kaltwasser JP; Said l-Hadj H; Staffenberger L
    Onkologie; 1989 Aug; 12 Suppl 1():5-8. PubMed ID: 2685697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton NMR spectroscopy of plasma lipoproteins in the experimental Lewis lung carcinoma.
    Leray G; Quemener V; Le Rumeur E; Benoist L; Auvray E; de Certaines JD
    Anticancer Res; 1992; 12(4):1227-31. PubMed ID: 1503413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceruloplasmin as a marker of neoplastic activity in rabbits bearing the VX-2 carcinoma.
    Ungar-Waron H; Gluckman A; Spira E; Waron M; Trainin Z
    Cancer Res; 1978 May; 38(5):1296-9. PubMed ID: 639063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organization of the core lipids of lipoproteins from normal and cholesterol-fed rabbits. A proton nuclear magnetic resonance study.
    Kroon PA; Seidenberg J
    Biochemistry; 1982 Dec; 21(25):6483-8. PubMed ID: 7150570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.
    Fossel ET; Carr JM; McDonagh J
    N Engl J Med; 1986 Nov; 315(22):1369-76. PubMed ID: 3022146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prostatic tumors. Detection by proton nuclear magnetic resonance spectroscopy of plasma lipoproteins].
    Nabholtz JM; Tremeaux JC; Rossignol A; Farnier M; Gambert P; Briet S; Guerrin J
    J Urol (Paris); 1989; 95(4):209-12. PubMed ID: 2477463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of aliphatic lipid proton NMR linewidths by malignant tumors in guinea pigs.
    Fossel ET; Dvorak HF; Carr JM; McDonagh J
    Eur J Cancer; 1990 Jan; 26(1):29-32. PubMed ID: 2138474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipoprotein concentrations and hepatic lesions in obese cats undergoing weight loss.
    Dimski DS; Buffington CA; Johnson SE; Sherding RG; Rosol TJ
    Am J Vet Res; 1992 Jul; 53(7):1259-62. PubMed ID: 1497199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertonic saline-augmented radiofrequency ablation of the VX-2 tumor implanted in the rabbit kidney: a short-term survival pilot study.
    Munver R; Threatt CB; Delvecchio FC; Preminger GM; Polascik TJ
    Urology; 2002 Jul; 60(1):170-5. PubMed ID: 12100957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.